That does not mean calories stop mattering. It means the hormonal environment you are dieting in is part of the picture, and unlike willpower, it is measurable. Fasting insulin and a short list of related markers can show where you sit years before a standard glucose test shifts.
Insulin is the hormone that moves fuel out of the bloodstream and into cells, and it is the main signal that tells the body to store rather than release energy. After a meal, carbohydrate is broken down into glucose, glucose enters the blood, and the pancreas releases insulin in response. Insulin then opens the door for glucose to enter muscle and liver cells, where it is burned or stored as glycogen.
That is only half the job. Insulin is also a powerful brake on fat release. Fat cells constantly cycle between storing triglyceride and releasing fatty acids into circulation for other tissues to burn. Insulin suppresses that release and encourages storage. In a healthy rhythm this is elegant. Insulin rises after eating, storage dominates for a few hours, insulin falls, and the body shifts back toward burning stored fuel between meals and overnight.
Insulin also acts on the kidneys, blood vessels, ovaries and brain, which is why a marker most people think of as a diabetes test shows up in conversations about blood pressure, fertility and cognition. The point to hold onto is simple. Insulin is a storage signal, and how much of it you need to keep blood sugar normal says a great deal about how your metabolism is running.
Insulin resistance means cells respond less to a given amount of insulin, so the pancreas compensates by releasing more. The headline consequence is that blood sugar can look completely normal while insulin runs high, sometimes for years. This compensated phase is where most people actually live, and it is invisible on a glucose test alone.
Mechanistically, several things appear to drive it. Muscle and liver cells accumulate fat inside them when energy intake chronically exceeds what those tissues can burn or safely store, and that internal lipid load interferes with insulin signalling. Fat tissue that is full and under strain releases more free fatty acids and inflammatory signals, which further blunt the signal. Physical inactivity reduces the muscle's appetite for glucose. Poor sleep, chronic stress and some medications push in the same direction.
The result is a feedback loop rather than a single cause. Higher insulin promotes storage, more stored fat in the wrong places worsens signalling, and signalling that is worse requires still more insulin. Importantly, this is a spectrum, not an on or off state. Two people can both have normal fasting glucose and be in very different places on that spectrum, and the only way to know which is which is to measure insulin alongside glucose rather than instead of it.
Both directions have support, and in most people they operate at once. Carrying excess fat, particularly around the abdomen and liver, reliably worsens insulin signalling. But the reverse arrow is real too. In a cohort of men without diabetes, elevated fasting insulin at baseline was associated with a greater risk of developing abdominal obesity over follow-up[1], which is the pattern you would expect if the hormonal state precedes and encourages the fat gain rather than only following it.
The loop also explains why body weight alone is a poor proxy for metabolic health. Work in adolescents found that insulin resistance calculated from fasting values strongly influenced whether obesity was classified as metabolically healthy[2]. Some people carry extra weight with largely preserved insulin sensitivity. Others carry very little and are already compensating hard.
For practical purposes, the useful framing is that insulin resistance makes weight gain easier and weight loss slower, while weight gain makes insulin resistance more likely. Neither is destiny. Because the loop runs in both directions, intervening at either point can loosen it, which is why improvements in diet quality, muscle mass and sleep often show up in insulin numbers before they show up convincingly on the scale.
Related: How to Lose Weight With Insulin Resistance (What Works)
Elevated insulin shifts the balance of fat tissue toward storing and away from releasing, so you spend more of the day in storage mode and less in burning mode. Fat cells take up circulating triglyceride more readily when insulin is high, and the enzyme machinery that breaks stored fat down for export is suppressed. That suppression is one of insulin's most sensitive actions, meaning it takes relatively little insulin to keep the brake on.
In someone with good insulin sensitivity, insulin rises after a meal, does its job, and falls within a few hours, leaving long windows where fat release proceeds normally. In someone compensating with high insulin, those windows shrink. The body is still mobilising fat, just less of it, for less of the day.
There is a second effect worth understanding. When fat tissue reaches the limit of what it can comfortably store, excess lipid spills into the liver, muscle and around the organs. Visceral and liver fat are more metabolically disruptive than fat stored under the skin, and they are closely tied to the insulin picture. This is why two people at the same weight can have very different fasting insulin values, and why waist measurement often tracks metabolic markers better than body weight does.
None of this suspends energy balance. It changes the terms on which energy balance operates, and it changes how the same deficit feels.
Appetite is harder to manage in this state because insulin interacts with the brain systems that regulate fuel availability and satiety. Insulin crosses into the brain and acts as a signal of energy status, and reduced central insulin sensitivity may blunt that signal, so the brain may receive a weaker message that fuel is plentiful.
There is also a straightforward blood sugar component. A large, rapidly absorbed carbohydrate load triggers a large insulin response. If that response overshoots, glucose can fall faster and further than it rose, and the resulting dip tends to arrive with hunger, shakiness, irritability and a strong pull toward fast carbohydrate. Eat accordingly, and the cycle repeats a few hours later. People often describe this as needing to eat every two or three hours, or feeling hungrier after breakfast than before it.
Layer on the fat release problem and the picture makes sense. If stored fat is less available as fuel between meals, the body leans harder on incoming food, and appetite rises to match. The subjective experience is of weak willpower. The physiology is of a fuel supply that has been partly locked away.
This matters practically, because it reframes the fix. Meals built to produce a smaller, flatter insulin response tend to reduce the hunger swings, which makes a sustainable intake easier to hold without white-knuckling it.
A stall usually reflects some combination of reduced energy expenditure, water shifts, and intake drifting upward, and insulin resistance can influence all three. It is worth saying plainly that insulin resistance does not create energy from nothing. Fat loss still requires a sustained deficit. What changes is how hard that deficit is to create and maintain.
First, high insulin states often come with lower spontaneous movement, because energy feels scarcer and fatigue after meals is more common. That drop in daily activity can quietly offset a deliberate deficit. Second, insulin affects sodium handling at the kidney, so changes in carbohydrate intake and insulin levels produce real swings in water retention that mask fat loss on the scale for days or weeks. Third, appetite pressure makes small intake drift more likely, and small drift closes small deficits.
There is also the composition question. If training stimulus and protein intake are low, more of the lost mass can come from lean tissue, which lowers resting expenditure and makes the next phase harder. Measuring waist circumference, strength and how clothes fit alongside body weight gives a far more honest read than the scale alone.
If progress has genuinely stalled despite consistent effort, that is a reasonable moment to measure rather than guess, and to review the plan with a clinician who can see the whole picture.
Fasting insulin is measured in µU/mL after an overnight fast, and most labs report a wide reference range that is designed to flag disease rather than to describe an ideal metabolic state.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Fasting insulin | 2 to 18 µU/mL | 2 to 5 µU/mL |
The gap between those two columns is the whole point. A result of 15 µU/mL sits inside the standard reference range and would usually be reported without comment, yet it is several times higher than the lower end and generally reflects a pancreas working hard to hold glucose steady. Standard reference ranges are built from the distribution of values in a general population, and in a population where insulin resistance is common, the upper end of normal is not the same as healthy.
FitScript's optimal range is an optimization target used to guide interpretation, not a diagnostic cut-off, and only a clinician can interpret a value in the context of a whole person. Reference ranges themselves vary by laboratory, assay, age and sex, so always read a result against the range printed on your own report. Insulin assays in particular are not fully standardised between labs, which is another reason to track your trend using the same laboratory where possible rather than comparing single values across providers.
A fasting insulin above the optimal range most often reflects compensation, meaning the pancreas is releasing extra insulin to keep blood glucose in range. It is an observation, not a diagnosis, and no single value identifies a disease.
What makes an elevated result worth attention is how consistently it tracks with other outcomes. Meta-analysis of cohort studies has linked higher fasting insulin and insulin resistance to increased risk of developing hypertension in general populations[3], and pooled data in adults without diabetes have associated higher fasting insulin with cardiovascular and all-cause mortality risk[4]. A dose-response meta-analysis also reported an association between fasting insulin and cancer-related mortality in non-diabetic adults[5]. Elevated fasting insulin has been associated with a higher risk of microalbuminuria, an early marker of kidney stress[6], and genetic approaches have been used to explore the pathways that may link fasting insulin to coronary artery disease[7].
The reach extends further. Higher fasting insulin has been associated with cognitive decline in older women without diabetes[8], and with endogenous hormone patterns and breast density in premenopausal women[9]. These are associations in populations, not predictions about an individual.
The practical meaning is this. A suboptimal fasting insulin is an early, actionable signal rather than a verdict, and it is worth discussing with a clinician who can look at it alongside your history and your other results.
A fasting insulin in the lower part of the range usually suggests the body is maintaining normal blood sugar without working hard, which is what good insulin sensitivity looks like. In most healthy adults that is a reassuring finding, particularly when fasting glucose and HbA1c are also unremarkable.
It is not an automatic all-clear, for two reasons. The first is that fasting insulin captures one moment in a 24-hour cycle. Someone can have an acceptable fasting value and still produce an exaggerated insulin response after meals, which is why post-meal glucose, HbA1c and symptoms matter alongside the fasted number.
The second is more technical. Fasting insulin reflects more than just how much insulin the pancreas secretes. Research has shown that it also reflects how quickly the liver clears insulin from circulation, so two people with the same measured value can have genuinely different underlying physiology[10]. Differences in clearance are one reason interpretation belongs with a clinician rather than with a single number read in isolation.
A genuinely low value in someone with symptoms such as unexplained weight loss, frequent low blood sugar episodes or persistent fatigue is a different situation, and that combination is worth discussing with a clinician promptly rather than monitoring at home.
Plenty, which is why a single result is best read as one data point in a trend. Sleep is near the top of the list. Short or fragmented sleep may reduce insulin sensitivity measurably within days, and a few bad nights before a blood draw can move your number.
Physical activity works in the opposite direction. Muscle is the largest site of glucose disposal, and contracting muscle takes up glucose through a pathway that does not depend on insulin. A single session of training improves insulin sensitivity for a period afterward, and regular training plus more muscle mass raises the baseline. Equally, a week of unusual inactivity or illness can push a result upward temporarily.
Other contributors include chronic psychological stress and elevated cortisol, acute illness and inflammation, alcohol intake in the days before testing, pregnancy, and the normal hormonal changes of perimenopause and menopause. Polycystic ovary syndrome is strongly associated with insulin resistance. Genetics and family history matter too, and some people compensate with high insulin at a body weight that looks entirely unremarkable.
When you test matters as much as what you test. Standardise the conditions, fast properly, avoid unusual training or drinking the day before, and compare like with like over time.
In routine practice it is estimated from fasting bloods rather than measured directly. The reference method is a hyperinsulinemic-euglycemic clamp, a specialist procedure that is not used for ordinary testing. What you will realistically encounter is a fasted blood draw reporting insulin and glucose, often with HbA1c and a lipid panel.
From fasting insulin and fasting glucose, a calculated index called HOMA-IR estimates insulin resistance. It is useful because it combines both halves of the picture. Someone whose glucose is held normal only by high insulin scores differently from someone whose glucose is normal with low insulin, even though the glucose values look identical. Cut-offs for HOMA-IR are not standardised across laboratories and assays, so the index is best used to track direction over time rather than to label a person.
An oral glucose tolerance test with insulin measured alongside glucose gives a more dynamic view, showing how large and how prolonged the insulin response is after a glucose load. It takes a few hours and is ordered selectively. Continuous glucose monitoring adds real-world detail about post-meal patterns, though it measures glucose rather than insulin.
Preparation is straightforward. Fast overnight, usually for 8 to 12 hours, drink water, and take the draw in the morning where possible. Ask your clinician about timing if you take medications that affect blood sugar, and never stop a prescribed medication to prepare for a test.
Fasting insulin becomes far more informative when it is read next to glucose, long-term glycemic control and the lipid pattern, because insulin resistance leaves fingerprints across all of them.
| Marker | What it adds | Typical lab reference range |
|---|---|---|
| Fasting glucose | Shows whether blood sugar is still being held in range | Commonly 65 to 99 mg/dL (3.6 to 5.5 mmol/L) |
| Hemoglobin A1c | Reflects average glucose over roughly the preceding three months | Commonly reported as below 5.7% |
| HOMA-IR | Calculated from fasting insulin and glucose together | Varies by lab and assay, no single agreed cut-off |
| Triglycerides | Often rises when the liver is handling excess fuel | Commonly below 150 mg/dL |
| HDL cholesterol | Frequently falls in insulin-resistant patterns | Differs by sex, see your own report |
| Triglyceride to HDL ratio | A simple read on the lipid pattern tied to insulin signalling | Reported variably, not standardised across labs |
These ranges are typical laboratory reference ranges and vary by laboratory, age and sex, so read them against the ranges printed on your own results.
Beyond this core group, clinicians often look at liver enzymes such as ALT, which can reflect fat accumulating in the liver, along with markers of inflammation, uric acid, thyroid function and, where relevant, sex hormones. Waist circumference and blood pressure cost nothing and add real information. The pattern across several markers tells a much clearer story than any one value, which is the entire argument for testing a panel rather than a single number.
The approaches with the best support are unglamorous and they work on both sides of the loop at once, reducing the insulin signal and improving how tissues respond to it.
Start with protein and fibre at every meal. Both slow gastric emptying, flatten the glucose curve and improve satiety, which makes a deficit easier to hold without constant hunger. Adequate protein also protects lean mass during weight loss, which preserves the tissue that disposes of most of your glucose.
Adjust carbohydrate quality before quantity. Replacing rapidly absorbed refined carbohydrate and sugar-sweetened drinks with whole grains, legumes, vegetables and whole fruit lowers the size of the insulin response without eliminating a food group. Cross-sectional analysis of national survey data has associated healthier plant-based dietary patterns with lower fasting insulin[11], though cross-sectional work cannot establish cause. The practical version is that a diet built mostly from minimally processed foods tends to produce lower insulin exposure across the day.
Resistance training is the highest-leverage exercise change, because building and using muscle expands glucose disposal capacity. Two to four sessions a week is a reasonable framework. Add regular walking, especially after meals, where even ten to fifteen minutes blunts the post-meal glucose rise.
Then defend sleep and manage stress deliberately, since both independently affect insulin sensitivity. Finally, give it time. Insulin sensitivity often improves before substantial weight loss appears, so judge progress on waist, strength, energy and repeat bloodwork rather than the scale alone.
Medication is a clinical decision, and a licensed provider evaluates whether any prescription treatment is appropriate based on your history, your results and your goals. No article can make that call, and this one will not give doses, schedules or administration guidance for any therapy.
What is useful to understand is the general landscape. Some medications used in metabolic care work primarily on the liver's glucose output and on insulin sensitivity. Other agents address blood pressure, lipids or related conditions that frequently travel alongside insulin resistance. Each carries its own eligibility criteria, monitoring requirements and side effect profile, and each requires evaluation by a licensed provider.
Supplements are a separate category, and how well established each one is varies considerably by compound. Some, such as magnesium in people who are deficient, have a plausible rationale. Others are marketed far ahead of their data. Peptides and similar interventions remain experimental and clinician-gated, and they should not be self-sourced.
The sequence that makes sense for most people is to measure first, change the modifiable inputs, retest, and then discuss with a clinician whether anything further is warranted. Medication works best layered on top of nutrition, training and sleep, not as a replacement for them.
Any result outside your laboratory's reference range is worth a conversation, and so is a result inside the range that sits well above the optimal target or that has climbed across repeat tests. A trend moving steadily in the wrong direction is often more informative than any single value.
Bring it forward sooner if you have symptoms. Increased thirst or urination, unexplained weight change, blurred vision, persistent fatigue, recurrent infections or slow-healing wounds are all worth discussing with a clinician promptly rather than monitoring at home. The same applies if you have a family history of type 2 diabetes, a history of gestational diabetes, polycystic ovary syndrome, or rising blood pressure alongside a suboptimal insulin result.
Also raise it when effort is not matching results. If you have held a consistent nutrition and training approach for several months without the change you expected, testing turns a frustrating guessing game into a question that can actually be answered.
This article is educational and is not medical advice. Discuss your results and any proposed treatment with a clinician or licensed provider before acting on them, and never stop or change a prescribed medication on your own.
If you want to go deeper on the individual numbers, Fasting Insulin explains what the marker measures, fasting glucose and hemoglobin a1c cover the glucose side of the picture, homa ir explains the calculated index, and triglyceride hdl ratio shows how the lipid panel reflects insulin signalling. The Metabolic + Insulin panel groups these markers into one draw, and members get 150+ biomarkers tested per year with interpretation from Atlas, FitScript's AI health advisor.
It contributes to it. High insulin promotes fat storage and suppresses fat release, and elevated fasting insulin is associated with later development of abdominal obesity. Weight gain also worsens insulin signalling, so the two reinforce each other. Energy balance still applies, but the hormonal setting makes gain easier and loss slower.
Work on both the insulin signal and tissue sensitivity. Build meals around protein, fibre and minimally processed carbohydrate, train with resistance work two to four times a week, walk after meals, and protect sleep. Keep a modest, sustainable deficit, and track waist and strength alongside the scale.
Prioritise consistency over severity. Crash dieting tends to cost lean mass, which lowers glucose disposal capacity and makes maintenance harder. A moderate deficit with adequate protein, regular strength training and steady daily movement improves insulin sensitivity while preserving muscle. Retest your bloodwork after a few months to see what changed.
Measure first, then adjust. Fasting insulin, glucose, HbA1c and the lipid pattern show where you actually are, which beats guessing. From there, improve carbohydrate quality, raise protein and fibre, add resistance training and sleep consistently. Discuss persistent stalls and any medication question with a clinician or licensed provider.
Yes. Some people compensate with high insulin at a body weight that looks entirely unremarkable, often with fat stored in the liver or around the organs rather than under the skin. Fasting glucose can stay normal in this situation, which is why measuring fasting insulin alongside glucose adds information.
Because the pancreas is compensating. Extra insulin keeps glucose in range, so glucose is often the last marker to shift. That compensated phase can last years and is invisible on a glucose test alone. Measuring insulin alongside glucose, or calculating HOMA-IR from both, reveals the effort behind a normal result.
It varies, and no timeline is guaranteed. Single exercise sessions and improved sleep can shift insulin sensitivity within days, while meaningful changes in fasting insulin usually follow weeks to months of consistent nutrition, training and sleep. Retesting under similar conditions, at the same lab, gives the clearest read on progress.
Yes, fasting insulin is measured after an overnight fast, commonly 8 to 12 hours, with water allowed. Morning draws are preferred for consistency. Avoid alcohol and unusual training the day before, since both can shift results. Ask your clinician about timing if you take medications that affect blood sugar.
No. A single elevated value is an observation, not a diagnosis, and no disease is inferred from one marker. It commonly reflects compensation, meaning more insulin is needed to hold glucose steady. It is suboptimal rather than conclusive, and it is worth discussing with a clinician alongside your other results.